Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - propranolol hydrochloride, quantity: 160 mg - capsule, modified release - excipient ingredients: gelatin; maize starch; sucrose; shellac; purified talc

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - propranolol hydrochloride, quantity: 10 mg - tablet - excipient ingredients: povidone; maize starch; lactose monohydrate; quinoline yellow; sunset yellow fcf aluminium lake; magnesium stearate; sodium starch glycollate - angina pectoris; hypertension; prevention of migraine; cardiac dysrhythmias: certain intrinsic cardiac dysrhythmias; dysrhythmias associated with thyrotoxicosis; anxiety tachycardia; certain drug-induced dysrhythmias (eg tachycardia due to digitalis or adrenaline (epinephrine) overdosage); essential tremor, including familial and senile tremor; phaeochromocytoma (only with concurrent alpha-receptor blockade); hypertrophic subaortic stenosis; suspected or definite myocardial infarction; fallot?s tetralogy

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

ipca pharma (australia) pty ltd - propranolol hydrochloride, quantity: 10 mg - tablet - excipient ingredients: quinoline yellow; povidone; sunset yellow fcf aluminium lake; sodium starch glycollate; magnesium stearate; lactose monohydrate; maize starch - angina pectoris; hypertension; prevention of migraine; cardiac dysrhythmias: certain intrinsic cardiac dysrhythmias; dysrhythmias associated with thyrotoxicosis; anxiety tachycardia; certain drug-induced dysrhythmias (eg tachycardia due to digitalis or adrenaline overdosage); essential tremor, including familial and senile tremor; phaeochromocytoma (only with concurrent alpha-receptor blockade); hypertrophic subaortic stenosis; suspected or definite myocardial infarction; fallot?s tetralogy

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

ipca pharma (australia) pty ltd - propranolol hydrochloride, quantity: 10 mg - tablet - excipient ingredients: lactose monohydrate; magnesium stearate; sunset yellow fcf aluminium lake; povidone; quinoline yellow; maize starch; sodium starch glycollate - angina pectoris; hypertension; prevention of migraine; cardiac dysrhythmias: certain intrinsic cardiac dysrhythmias; dysrhythmias associated with thyrotoxicosis; anxiety tachycardia; certain drug-induced dysrhythmias (eg tachycardia due to digitalis or adrenaline overdosage); essential tremor, including familial and senile tremor; phaeochromocytoma (only with concurrent alpha-receptor blockade); hypertrophic subaortic stenosis; suspected or definite myocardial infarction; fallot?s tetralogy

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

gm pharma international pty ltd - propranolol hydrochloride, quantity: 10 mg - tablet - excipient ingredients: povidone; quinoline yellow; sodium starch glycollate; sunset yellow fcf aluminium lake; lactose monohydrate; magnesium stearate; maize starch - angina pectoris; hypertension; prevention of migraine; cardiac dysrhythmias: certain intrinsic cardiac dysrhythmias; dysrhythmias associated with thyrotoxicosis; anxiety tachycardia; certain drug-induced dysrhythmias (eg tachycardia due to digitalis or adrenaline overdosage); essential tremor, including familial and senile tremor; phaeochromocytoma (only with concurrent alpha-receptor blockade); hypertrophic subaortic stenosis; suspected or definite myocardial infarction; fallot?s tetralogy

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

ipca pharma (australia) pty ltd - propranolol hydrochloride, quantity: 10 mg - tablet - excipient ingredients: sunset yellow fcf aluminium lake; povidone; lactose monohydrate; maize starch; magnesium stearate; quinoline yellow; sodium starch glycollate - angina pectoris; hypertension; prevention of migraine; cardiac dysrhythmias: certain intrinsic cardiac dysrhythmias; dysrhythmias associated with thyrotoxicosis; anxiety tachycardia; certain drug-induced dysrhythmias (eg tachycardia due to digitalis or adrenaline overdosage); essential tremor, including familial and senile tremor; phaeochromocytoma (only with concurrent alpha-receptor blockade); hypertrophic subaortic stenosis; suspected or definite myocardial infarction; fallot?s tetralogy

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - propranolol hydrochloride, quantity: 40 mg - tablet, film coated - excipient ingredients: magnesium stearate; croscarmellose sodium; calcium carbonate; pregelatinised maize starch; gelatin; titanium dioxide; hypromellose; sunset yellow fcf; erythrosine; macrogol 400 - 1. angina pectoris. 2. hypertension. 3. prevention of migraine. 4. cardiac dysrythmias: certain intrinsic cardiac dysrythmias; dysrythmias associated with thyrotoxicosis; anxiety tachycardia; certain drug induced dysrythmias (eg. tachycardia due to digitalis or adrenaline overdosage). 5. essential tremor including familial and senile tremor. 6. phaeochromocytoma (only with concurrent alpha antagonist). 7. hypertrophic subaortic stenosis. 8. suspected or definite myocardial infarction.

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

physicians total care, inc. - propranolol hydrochloride (unii: f8a3652h1v) (propranolol - unii:9y8nxq24vq) - propranolol hydrochloride 10 mg - propranolol hydrochloride tablets are indicated in the management of hypertension. they may be used alone or used in combination with other antihypertensive agents, particularly a thiazide diuretic. propranolol hydrochloride tablets are not indicated in the management of hypertensive emergencies. propranolol hydrochloride tablets are indicated to decrease angina frequency and increase exercise tolerance in patients with angina pectoris. propranolol hydrochloride tablets are indicated to control ventricular rate in patients with atrial fibrillation and a rapid ventricular response. propranolol hydrochloride tablets are indicated to reduce cardiovascular mortality in patients who have survived the acute phase of myocardial infarction and are clinically stable. propranolol hydrochloride tablets are indicated for the prophylaxis of common migraine headache. the efficacy of propranolol in the treatment of a migraine attack that has started has not been established, and propranolol is not indicated for

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

rebel distributors corp. - propranolol hydrochloride (unii: f8a3652h1v) (propranolol - unii:9y8nxq24vq) - propranolol 60 mg - propranolol hydrochloride tablets are indicated in the management of hypertension. they may be used alone or used in combination with other antihypertensive agents, particularly a thiazide diuretic. propranolol hydrochloride tablets are not indicated in the management of hypertensive emergencies. propranolol hydrochloride tablets are indicated to decrease angina frequency and increase exercise tolerance in patients with angina pectoris. propranolol hydrochloride tablets are indicated to control ventricular rate in patients with atrial fibrillation and a rapid ventricular response. propranolol hydrochloride tablets are indicated to reduce cardiovascular mortality in patients who have survived the acute phase of myocardial infarction and are clinically stable. propranolol hydrochloride tablets are indicated for the prophylaxis of common migraine headache. the efficacy of propranolol in the treatment of a migraine attack that has started has not been established, and propranolol is not indicated for such use. pr

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

mylan pharmaceuticals inc. - propranolol hydrochloride (unii: f8a3652h1v) (propranolol - unii:9y8nxq24vq), hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th) - propranolol hydrochloride 40 mg - propranolol hydrochloride and hydrochlorothiazide tablets, usp are indicated in the management of hypertension. this fixed combination is not indicated for initial therapy of hypertension. hypertension requires therapy titrated to the individual patient. if the fixed combination represents the dosage so determined, its use may be more convenient in patient management. propranolol is contraindicated in 1) cardiogenic shock; 2) sinus bradycardia and greater than first-degree block; 3) bronchial asthma; 4) congestive heart failure (see warnings) unless the failure is secondary to a tachyarrhythmia treatable with propranolol. hydrochlorothiazide is contraindicated in patients with anuria or hypersensitivity to this or other sulfonamide-derived drugs.